A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemyIntra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal TreatmentInitial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study.Recommendations for intra-abdominal infections consensus report.Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?Lessons from uncertainty on antifungal treatment in ICU.The EMPIRICUS trial-the final nail in the coffin of empirical antifungal therapy in the intensive care unit?The paradox of the evidence about invasive fungal infection prevention.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies.Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences.What every intensivist should know about the management of peritonitis in the intensive care unit.(1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial
P2860
Q26739860-501E3654-7EF1-49BC-A488-CF2ABE59795AQ26745677-1773E1F4-9E35-4366-8C9D-D442FFE31A88Q36001726-1C1FC5E6-21B2-4BA2-A560-FF2656ED7D19Q36257873-A38D788C-5EEF-4DBF-9043-5C94280B12F4Q37594389-D740606E-F7CA-4CE9-9310-E3FC4C37032DQ40383385-076FD99C-25DA-42E1-94C8-633A5FAABB1FQ42148479-8AA5F09C-0F4D-47DD-98AA-A13D0F10792EQ42362382-5EDAE665-0FC2-4C2B-A50B-271FC327B1B4Q42854908-D95FB5B0-51C1-4222-97D2-6E936114AF12Q47749829-CF602A6D-7C3F-4600-BDFE-07E7EA040F92Q49379463-86D7B98E-50E2-4824-B5D2-CF4950E658E8Q49613087-B63F7D42-834F-4CB5-B139-FD97E2949DFBQ49803837-AB428A29-05D0-41F4-A46A-FC8FE332326EQ55091146-CD7A3CA7-A378-4C46-B5AB-329DA67E43F2Q58765160-A152AE0C-7499-4118-8588-FC6CF9B91EF9
P2860
A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A randomized, placebo-controll ...... or intra-abdominal infections.
@ast
A randomized, placebo-controll ...... or intra-abdominal infections.
@en
type
label
A randomized, placebo-controll ...... or intra-abdominal infections.
@ast
A randomized, placebo-controll ...... or intra-abdominal infections.
@en
prefLabel
A randomized, placebo-controll ...... or intra-abdominal infections.
@ast
A randomized, placebo-controll ...... or intra-abdominal infections.
@en
P2093
P2860
P50
P356
P1476
A randomized, placebo-controll ...... or intra-abdominal infections.
@en
P2093
Andreas Karas
Cristóbal León
George Dimopoulos
Juan Carlos Valía
Lorraine Tweddle
Malcolm Brown
Philippe Eggimann
Philippe Montravers
Stefan Utzolino
Stephen Phillips
P2860
P304
P356
10.1093/CID/CIV707
P407
P577
2015-08-13T00:00:00Z